Like neutron stars and the certain executive branch politicians, Materials and Methods (M&M) sections just keep getting denser. Not content with shrinking the fonts to subatomic scale, many journals ...
MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine MOUNTAIN VIEW, Calif., Jan 16, 2008 -- MAP Pharmaceuticals, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results